Pathways critical for the development, progression, and maintenance of
GU (prostate & bladder), lung, and GI (liver& pancreas) cancers.
​
Transitions between epithelial and mesenchymal cellular states and their implications for tumorigenesis, metastasis, metabolism, treatment resistance, and radiation-induced fibrosis.

Novel targeted agents as tumor selective radiosensitizers to increase the therapeutic ratio of clinical radiotherapy.